Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Patterson Companies (PDCO) Q1 Earnings: What's In Store?

Published 08/17/2016, 09:13 PM
Updated 07/09/2023, 06:31 AM
PDCO
-
BBY
-
AVGO
-
ASND
-

Patterson Companies Inc (NASDAQ:PDCO) is set to report first-quarter 2017 results on Aug 25, before the opening bell. Last quarter, the company reported adjusted earnings of 77 cents per share from continuing operations, beating the Zacks Consensus Estimate by a penny.

However, the four-quarter trailing average surprise came negative at 4.21%.

Let’s see how things are shaping up prior to this announcement.

Factors at Play

We believe a growing and diversified product portfolio, strong veterinary business prospects, accretive acquisitions and strategic partnerships are key catalysts for the company.

Exclusively, the partnership of Patterson Companies with Sirona in bringing high-tech CEREC units to dental groups registered with American Dental Partners is likely to help the company gain market traction.

We are also highly optimistic about the lucrative opportunities in the companion-animal and production animal segment. The company is expected to primarily benefit from improving end markets which would drive top-line growth over the long haul.

PATTERSON COS Price and EPS Surprise

PATTERSON COS Price and EPS Surprise | PATTERSON COS Quote

Earnings Whispers

However, our proven model does not conclusively show that Patterson Companies is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.

Zacks ESP: Patterson Companies currently has an Earnings ESP of -3.92%. This is because the Most Accurate estimate stands at 49 cents while the Zacks Consensus Estimate remains at 51 cents.

Zacks Rank: Patterson Companies currently carries a Zacks Rank #4 (Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revision.

Stocks to Consider

Here are some companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:

Best Buy Co., Inc (NYSE:BBY) with an Earnings ESP of +4.76% and a Zacks Rank #3.

Ascendis Pharma A/S Inc. (NASDAQ:ASND) with an Earnings ESP of +7.46% and a Zacks Rank #2.

Broadcom Limited (NASDAQ:AVGO) with an Earnings ESP of +0.87% and a Zacks Rank #3.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


BROADCOM LTD (AVGO): Free Stock Analysis Report

PATTERSON COS (PDCO): Free Stock Analysis Report

BEST BUY (BBY): Free Stock Analysis Report

ASCENDIS PHARMA (ASND): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.